logo

For the Inventor, By the Inventor

St. Laurent, Canada

Amedeo Failli

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Montreal, C (1976)
  • Montreal, CA (1976 - 1977)
  • St. Laurent, CA (1979 - 1985)

Company Filing History:

goldMedal11 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal3 out of 117 
 
Ayerst, Mckenna & Harrison, Inc.
 patents

Years Active: 1976-1985

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4529731 - Thiadiazolediamine derivative with histamine H-2 receptor inhibiting (1985-07-16),
2. 4401656 - N-Substituted dimeric cyclopeptide derivatives (1983-08-30),
3. 4351828 - N-Substituted cyclopeptide derivatives (1982-09-28),
4. 4309348 - Tricyclic indole derivatives (1982-01-05),
5. 4252795 - N-substituted dimeric cyclopeptide derivatives and preparation thereof (1981-02-24),
6. 4237045 - N-substituted cyclopeptide derivatives and preparation thereof (1980-12-02),
7. 4235901 - 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof (1980-11-25),
8. 4179503 - 1-Hydroxyalkanamine pyrano[3,4-b]indole derivatives (1979-12-18),
9. 4033974 - Pyridylmethyl esters of N-(phenoxyalkanoyl)peptide derivatives (1977-07-05),
10. 4018912 - Tripeptide derivatives with central nervous system activity and (1977-04-19),
11. 4000284 - Phenoxyisobutyric acid salts (1976-12-28),
12. 4000122 - Novel hydrazinocarboxamide derivatives and preparation thereof (1976-12-28),
13. 3979380 - Derivatives of imidazolidin-2-ones and -2-thiones (1976-09-07),
14. 3956484 - Pyridylmethyl esters of N-(phenoxyalkanoyl)peptide derivatives for (1976-05-11),

Title: Amedeo Failli: Innovator in Pharmaceutical Chemistry

Introduction

Amedeo Failli is a notable inventor based in St. Laurent, Canada, recognized for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, Failli has developed innovative compounds that have the potential to improve health outcomes.

Latest Patents

Among his latest patents is a thiadiazolediamine derivative that acts as a long-acting histamine H-2 receptor antagonist. This compound, N-[2-(dimethylamino)ethyl]-N'-[3-[3-[(1-piperidinyl)methyl]phenoxy]-propyl]-1,2,5-thiadiazole-3,4-diamine, 1-oxide, is designed to inhibit gastric acid secretion, thereby preventing and alleviating ulcers. Another significant patent involves N-substituted dimeric cyclopeptide derivatives, which are useful for treating microbial infections. These compounds are characterized by a specific formula that includes various amino acid residues and functional groups.

Career Highlights

Failli has worked with prominent companies in the pharmaceutical industry, including American Home Products Corporation and Ayerst, McKenna & Harrison, Inc. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Amedeo Failli has collaborated with esteemed colleagues such as Hans U Immer and Manfred K Gotz. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in pharmaceutical research.

Conclusion

Amedeo Failli's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…